Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03867539 · ClinicalTrials.gov registry record · Phase 4
Exparel and Education to Avoid Opioids After Carpal Tunnel Release
A Phase 4 study of Carpal Tunnel Syndrome, sponsored by Kettering Health Network.
- Recruiting
- Registry status
- Phase 4
- Development phase
- 64
- Enrollment target
- 2
- Study locations
NCT03867539: Recruiting Phase 4 study of Carpal Tunnel Syndrome, sponsored by Kettering Health Network.
NCT03867539 is a Phase 4 study of Carpal Tunnel Syndrome that is actively recruiting participants, run by Kettering Health Network. The registered enrollment target is 64 participants, below the 220-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (71% lower). The trial reports 2 study locations across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03867539, a Phase 4 study of Carpal Tunnel Syndrome, is actively recruiting participants, sponsored by Kettering Health Network.
- RECRUITING
- Registry status
- Phase 4
- Development phase
- 64 participants
- Enrollment target
- 2
- Study locations
Study Summary
This trial seeks to use the long acting local anesthetic Exparel, in conjunction with opioid education, to attempt to avoid any post-operative opioid use following carpal tunnel surgery. This group will be compared with a "standard" group that receives non-liposomal bupivacaine, opioid education, and opioids.
Primary Outcome
The investigators aim to evaluate pain in either arm of the study, followed over a three day course. As several studies have shown pain to be wholly or mostly resolved by post-operative day three. Patients will answer questionnaire to include Visual Analog Scale for pain, and amount of pain medication taken. The Visual Analog Scale for pain ranges from a score of 0 to 10, with 0 being "no pain", 5 being "distressing pain", and 10 being "the worst pain imaginable"
Conditions Studied
Interventions
- OTHER Differing pain management strategy
Study Locations (2)
Ohio
- Orthopedic Associates of Southwest Ohio - Dayton
- Orthopedic Associates of Southwest Ohio - Dayton
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 64 participants |
| Start Date | 2019-02-15 |
| Est. Completion | 2025-03-31 |
| Phase | Phase 4 |
What NCT03867539 shows while recruiting
NCT03867539 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 64 participants, a relatively small participant target, below the 220-participant average among 21 other Carpal Tunnel Syndrome trials with a reported enrollment target (71% lower).
The record links to 1 condition, with Carpal Tunnel Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Differing pain management strategy is the first listed.
NCT03867539 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT03867539 about?
NCT03867539 is a clinical study titled "Exparel and Education to Avoid Opioids After Carpal Tunnel Release". This trial seeks to use the long acting local anesthetic Exparel, in conjunction with opioid education, to attempt to avoid any post-operative opioid use following carpal tunnel surgery. This group will be compared with a "standard" group that receives non-liposomal bupivacaine, opioid education, an...
What is the current status of trial NCT03867539?
This trial is currently recruiting. It is a Phase 4 study. The enrollment target is 64 participants. The study started on 2019-02-15. Estimated completion is 2025-03-31.
What conditions does trial NCT03867539 study?
This clinical trial studies the following conditions: Carpal Tunnel Syndrome.
What interventions are being tested in trial NCT03867539?
The interventions under investigation include: Differing pain management strategy (OTHER).
Who is sponsoring clinical trial NCT03867539?
This trial is sponsored by Kettering Health Network, which has 14 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03867539 being conducted?
This trial has 2 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Carpal Tunnel Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT03867539's enrollment target sits among peer trials
64 15th of 21 higher than 7 of 21 other Carpal Tunnel Syndrome trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Carpal Tunnel Syndrome trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Preoperative Antibiotics for Carpal Tunnel Release Surgery
COMPLETED · Phase 4
-
A Study Of Lidocaine Patch 5% Alone, Gabapentin Alone, And Lidocaine Patch 5% And Gabapentin In Combination For The Relief Of Pain In Patients With Diverse Peripheral Neuropathic Pain Conditions
COMPLETED · Phase 4
-
Carpal Arch Space Augmentation (CASA) Clinical Trial
RECRUITING · NA
-
Ultrasound Analysis of Human Carpal Tunnel System
RECRUITING
-
Effect of Cooling Therapy for Post-Operative Pain in Open Carpal Tunnel Release
RECRUITING · NA
-
Small Nerve Fiber Activity in Patients with Carpal Tunnel Syndrome Assessed Via Quantitative Sensory Testing
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01853631 · 64 participants · Phase 1
Activated T-Cells Expressing 2nd or 3rd Generation CD19-Specific CAR, Advanced B-Cell NHL, ALL, and CLL (SAGAN)
- NCT03739502 · 64 participants · Phase 2
A Randomized Phase II Study of Hyperbaric Oxygen in Improving Engraftment in Umbilical Cord Blood Stem Cell Transplant
- NCT03739814 · 64 participants · Phase 2
Inotuzumab Ozogamicin and Blinatumomab With or Without Ponatinib in Treating Patients With Newly Diagnosed, Recurrent, or Refractory CD22-Positive B-Lineage Acute Lymphoblastic Leukemia
- NCT03866408 · 64 participants · Early Phase 1
Insulin Regulation of Lipolysis and Lipolysis Proteins
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI